Release Date: 07/08/09 09:02 Summary: Resource Upgrade and Reserve Delineation Price Sensitive: Yes Download Document 163.38KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%